Usefulness of an in-vitro tuberculosis interferon-γ release assay (T-SPOT.TB) in the first-line check-up of uveitis patients

Annals of Medicine

Volumn 42, Issue 7, 2010, Pages 546-554

  Ball, Pierre Marie ^a   Pernollet, Martine ^a   Bouillet, Laurence ^a   Maurin, Max ^a   Pavese, Patricia ^a   Quesada, Jean Louis ^a   Romanet, Jean Paul ^a   Chiquet, Christophe ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

ELISPOT; interferon gamma release assay; T SPOT.TB; tuberculin skin test; tuberculosis; uveitis

Indexed keywords

BCG VACCINE; GAMMA INTERFERON;

ADULT; AGED; ARTICLE; BLOOD EXAMINATION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; IN VITRO STUDY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; OCULAR TUBERCULOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEROLOGY; THORAX RADIOGRAPHY; TUBERCULIN TEST; UVEITIS;

ADULT; AGED; BIOLOGICAL ASSAY; CELL COUNT; FEMALE; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS; UVEITIS;

EID: 77958054936     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2010.518155     Document Type: Article

References (33)

1. Bodaghi B, Cassoux N, Wechsler B, Hannouche D, Fardeau C, Papo T, et al. Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center. Medicine (Baltimore). 2001;80:263-70.
2. Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet. 2003;362:887-99.
3. Bodaghi B, LeHoang P. Ocular tuberculosis. Curr Opin Ophthalmol. 2000;11:443-8.
4. Gupta V, Gupta A, Rao NA. Intraocular tuberculosis\an update. Surv Ophthalmol. 2007;52:561-87.
5. Foster S. Tuberculosis. In: Foster S, Vitale AT, editors. Diagnosis and treatment of uveitis. Philadelphia: WB Saunders Company; 2002. p. 264-71.
6. Bansal R, Gupta A, Gupta V, Dogra MR, Bambery P, Arora SK. Role of anti-tubercular therapy in uveitis with latent/manifest tuberculosis. Am J Ophthalmol. 2008;146:772-9.
7. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis. 1993;17:968-75.
8. Lalvani A, Pathan AA, Durkan H, Wilkinson KA, Whelan A, Deeks JJ, et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specifi c T cells. Lancet. 2001;357:2017-21.
9. Lalvani A. Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest. 2007;131: 1898-906.
10. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008;149:177-84.
11. Andreu J, Caceres J, Pallisa E, Martinez-Rodriguez M. Radiological manifestations of pulmonary tuberculosis. Eur J Radiol. 2004;51:139-49.
12. Lee JJ, Chong PY, Lin CB, Hsu AH, Lee CC. High resolution chest CT in patients with pulmonary tuberculosis: characteristic fi ndings before and after antituberculous therapy. Eur J Radiol. 2008;67:100-4.
13. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509-16.
14. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-74.
15. Mazurek GH, LoBue PA, Daley CL, Bernardo J, Lardizabal AA, Bishai WR, et al. Comparison of a whole-blood inter-feron gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA. 2001; 286:1740-7.
16. Morimura Y, Okada AA, Kawahara S, Miyamoto Y, Kawai S, Hirakata A, et al. Tuberculin skin testing in uveitis patients and treatment of presumed intraocular tuberculosis in Japan. Ophthalmology. 2002;109:851-7.
17. Jones HE, Miller SD, Greenberg JH. Measurement of tuberculin reactions. N Engl J Med. 1972;287:721.
18. Sellam J, Hamdi H, Roy C, Baron G, Lemann M, Puechal X, et al. Comparison of in vitro-specifi c blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy. Ann Rheum Dis. 2007;66:1610-5.
19. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000;161: S221-47.
20. Alvarez S, McCabe WR. Extrapulmonary tuberculosis revisited: a review of experience at Boston City and other hospitals. Medicine (Baltimore). 1984;63:25-55.
21. Rose AM, Watson JM, Graham C, Nunn AJ, Drobniewski F, Ormerod LP, et al. Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998. Thorax. 2001;56:173-9.
22. Cordero-Coma M, Calleja S, Torres HE, Barrio ID, Franco M, Yilmaz T, et al. The value of an immune response to Mycobacterium tuberculosis in patients with chronic posterior uveitides revisited: utility of the new IGRAs. Eye (Lond). 2010;24:36-43.
23. Itty S, Bakri SJ, Pulido JS, Herman DC, Faia LJ, Tufty GT, et al. Initial results of QuantiFERON-TB Gold testing in patients with uveitis. Eye (Lond). 2009;23:904-9.
24. Ang M, Htoon HM, Chee SP. Diagnosis of tuberculous uvei-tis: clinical application of an interferon-gamma release assay. Ophthalmology. 2009;116:1391-6.
25. Mackensen F, Becker MD, Wiehler U, Max R, Dalpke A, Zimmermann S. QuantiFERON TB-Gold\a new test strengthening long-suspected tuberculous involvement in ser-piginous-like choroiditis. Am J Ophthalmol. 2008;146: 761-6.
26. Kim SH, Song KH, Choi SJ, Kim HB, Kim NJ, Oh MD, et al. Diagnostic usefulness of a T-cell-based assay for extrapulmonary tuberculosis in immunocompromised patients. Am J Med. 2009;122:189-95.
27. Lalvani A, Pathan AA, McShane H, Wilkinson RJ, Latif M, Conlon CP, et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specifi c T cells. Am J Respir Crit Care Med. 2001;163:824-8.
28. Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest. 2010;137:952-68.
29. Soborg B, Ruhwald M, Hetland ML, Jacobsen S, Andersen AB, Milman N, et al. Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with infl ammatory diseases. J Rheumatol. 2009;36:1876-84.
30. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007;146:340-54.
31. Leyten EM, Prins C, Bossink AW, Thijsen S, Ottenhoff TH, van Dissel J T, et al. Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specifi c interferon-gamma assay. Eur Respir J. 2007;29:1212-6.
32. Richeldi L, Bergamini BM, Vaienti F. Prior tuberculin skin testing does not boost QuantiFERON-TB results in paedi-atric contacts. Eur Respir J. 2008;32:524-5.
33. Al-Mezaine HS, Al-Muammar A, Kangave D, Abu El-Asrar AM. Clinical and optical coherence tomographic fi ndings and outcome of treatment in patients with presumed tuberculous uveitis. Int Ophthalmol. 2008;28:413-23.